Company: PSTV
Filing Date: 2025-04-11
Form Type: POS AM
Source: 0001193125-25-079109
Chunk: 28

Company: PLUS THERAPEUTICS, INC.
Filing Date: 2025-04-11
Form: POS AM
Chunk 28
---
 Plus Therapeutics, Inc. Series A Common Stock Purchase Warrant   |     |                           | 10-Q |     |             | 001-34375  |     |         |  4.7 |     |             | 08/14/2024 |
| 4.9     |     | Form of Amendment and Restatement of the Plus Therapeutics, Inc. Series B Common Stock Purchase Warrant   |     |                           | 10-Q |     |             | 001-34375  |     |         |  4.8 |     |             | 08/14/2024 |
| 5.1     |     | Opinion of Hogan Lovells US LLP                                                                           |     |                           | S-1  |     |             | 333-280061 |     |         |  5.1 |     |             | 06/07/2024 |
| 23.1*   |     | Consent of Independent Registered Public Accounting Firm                                                  |     |                           |      |     |             |            |     |         |      |     |             |            |
| 23.2    |     | Consent of Hogan Lovells US LLP (included in Exhibit 5.1)                                                 |     |                           | S-1  |     |             | 333-280061 |     |         | 23.2 |     |             | 06/07/2024 |
| 24.1    |     | Power of Attorney                                                                                         |     |                           | S-1  |     |             | 333-280061 |     |         | 24.1 |     |             | 06/07/2024 |
| 107     |     | Filing Fee Table                                                                                          |     |                           | S-1  |     |             | 333-280061 |     |         |  107 |     |             | 06/07/2024 |

| * | Filed herewith. |

II-3

Item 17. Undertakings (a) The undersigned registrant hereby undertakes: (1) To file, during any period in which offers or sales are being made, a post-effective amendment to this registration statement:

| (i) | to include any prospectus required by Section 10(a)(3) of the Securities Act of 1933; |

| (ii) | to reflect in the prospectus any facts or events arising after the effective